Boas Práticas de Farmácia Hospitalar - Portal da Saúde

18 Farmer K.C. (1999). Methods for Measuring and Monitoring Medication Regimen adherence
in clinical trial and clinical practice. Clin.Therp., 21(6), 1074-90
19 La Porte C.J.L.,Back D.J., Blaschke T., Boucher C.A.B., Fletcher C.V., Flexner C., Gerber
J.G., Kashuba A.D.M., Schapiro J., Burguer D.M. (2006) Update guidelines to perform
therapeutic drug monitoring for antiretroviral agents. Reviews in antiretroviral therapy (3):4-
14
20 Kappelhoff B.S., Crommentuym K.M.L., De Maat M.M.R., Mulder J.W., Huitema A.D.R.
Beijnen J.H.(2004) Practical guidelines to interpret plasma concentrations of antiretroviral
drugs. Clin Pharmcokinet, 43(13): 845-53
21 Broers B., Morabia A., Hirschel B. (1994). A cohort study of drug users compliance with
zidovudine treatment. Arch. Intern. Med., 154: 1121-7
22 Singh N., Squier C., Sivek C., Wagener M., Hong Ngunyen M., Yu V.L. (1996). Determinants
of compliance with antiretroviral therapy in patients with human immunodeficiency virus:
prospective assessment with implications for enhancing compliance. AIDS CARE, 8(3), 261-9
23 Paterson DL., Potoski B., Capiano B. (2002). Measurement of adherence to antiretroviral
medications. JAIDS, 31(Suppl 3), S103-6
24 Chesney M., Morin M., Sherr L. (2000) Adherence to HIV combination therapy. Soc Scien
& Med, 50, 1599-605
25 AIDS Clinical Trial Group (ACTG). ACTG Adhevence Baseline Questinaire, ACTG Adhevence
Follow up Questionaire. www.caps.ucsf.edu/tools/surveys/
26 Parinti J.J., Verdon R., Bazin C., Bouvet E., Massari V. (2001). The pills identification test:
a tool to assess adherence to ART. JAMA, 285(4), 412 (letter to editor)
27 Eldred L.J., Wu A.W., Chaisson R., Moore R.D. (1998). Adherence to antiretroviral and
Pneumocystis profylaxis in HIV disease. JAIDS, 18, 117-25
28 Bangsberg D.R., Hecht F., Clague H., Clague H., Charlebois E., Ciccarone D., Chesney
M., Moss A. (2001). Provider assessement of adherence to HIV antiretroviral therapy. JAIDS,
26, 435-42
29 Lee JY., Kusek J.W., Greene P., Bernhard S., Norris K., et al.(1996). Assessing medication
adherence by pill count and electronic monitoring in African Americam Study of kidney
disease and hypertension (AASK) pilot study. Am J Hypert, 9: 719-25
30 Fogarty L., Roter D., Larson S., Burke J., Gillespie J., Levy R. (2002). Patient Adherence
to HIV medication regimens: a reviw of published and abstract reports. Pat.Edu.Couns, 46(2),
93-108
31 Steiner J.F., Prochazka A.V. (1997). The assessment of refill compliance using pharmacy
records: methods, validity and application. J Clin Epidemiol, 50, 105-16
32 American Society of Health-System Pharmacist. ASHP Statement on the Pharmacist`s
Role in Care of Patients with HIV Infection. A. J. Health-Syst-Pharm.
33 Grupo Estudo SIDA. Recomendationes GESIDA/SEFH/PNS para mejorar la adherencia al
tratamento antirretroviral. Enferm. Infec. Microbiol. Clin. 2000;18:27-39
Aconselhamento
ao Doente
169